Brief: Sonnet Biotherapeutics Says FDA Has Cleared Co's Investigational New Drug Application For SON-1010

Sonnet Biotherapeutics Holdings

16/03/2022 11:07

March 16 (Reuters) - Sonnet Biotherapeutics Holdings Inc
 SONN.O :
    * SONNET BIOTHERAPEUTICS HOLDINGS INC -FDA HAS CLEARED
COMPANY'S
INVESTIGATIONAL NEW DRUG (IND) APPLICATION FOR SON-1010

Further company coverage:  SONN.O